Patients Ineligible Excision | Patients Ineligible Transplantation of liver | Patients Ineligible Local Ablation Therapy | Patients Ineligible Chemoembolization | Liver carcinoma | Liver tumor hypervascular | Foetoprotein Level
Item
patients not eligible for surgical resection, liver transplantation, local ablation techniques or chemoembolisation and with histologically proven liver carcinoma whenever possible or combination of radiologically documented hypervascular liver tumour and α foeto protein level ≥ 400 ng/ml
boolean
C0030705 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C0728940 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1512714 (UMLS CUI [2,2])
C0023911 (UMLS CUI [2,3])
C0030705 (UMLS CUI [3,1])
C1512714 (UMLS CUI [3,2])
C0547070 (UMLS CUI [3,3])
C0030705 (UMLS CUI [4,1])
C1512714 (UMLS CUI [4,2])
C0796679 (UMLS CUI [4,3])
C2239176 (UMLS CUI [5])
C0023903 (UMLS CUI [6,1])
C1512560 (UMLS CUI [6,2])
C0015950 (UMLS CUI [7,1])
C0441889 (UMLS CUI [7,2])
Informed Consent
Item
signed and dated approved patient informed consent form prior to enrollment into the study
boolean
C0021430 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status > 2
boolean
C1520224 (UMLS CUI [1])
Organ function Inadequate
Item
inadequate organ function:
boolean
C0678852 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
Absolute neutrophil count
Item
neutrophils (anc) < 1,500/mm3
boolean
C0948762 (UMLS CUI [1])
Hemoglobin measurement
Item
hemoglobin < 10g/dl
boolean
C0518015 (UMLS CUI [1])
Platelet Count measurement
Item
platelets < 100,000/mm3
boolean
C0032181 (UMLS CUI [1])
Elevated total bilirubin
Item
total bilirubin > 1.5 x uln
boolean
C0741494 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
asat, alat > 3 x uln
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Blood creatinine increased
Item
creatininemia > 1.5 x uln (or ≥ 2.0 mg/dl)
boolean
C0235431 (UMLS CUI [1])
INR raised
Item
inr > 1.6
boolean
C0853225 (UMLS CUI [1])
Liver Cirrhosis Child-Pugh Classification
Item
liver cirrhosis child pugh b or c (score > 6)
boolean
C0023890 (UMLS CUI [1,1])
C2347612 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
hba1c > 8%
boolean
C0474680 (UMLS CUI [1])
Absence Tumor Measurable lesion | Absence Tumor Lesion Evaluable
Item
no measurable or evaluable tumoral lesion
boolean
C0332197 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
C1513041 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0027651 (UMLS CUI [2,2])
C0221198 (UMLS CUI [2,3])
C1516986 (UMLS CUI [2,4])
Patient Ineligible Sorafenib
Item
patients not eligible for sorafenib therapy and for whom this therapy cannot be postponed by 3 weeks (during ave1642 single treatment period) in dose escalation part
boolean
C0030705 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C1516119 (UMLS CUI [1,3])
Exposure to IGF-1R Antibody Compound
Item
prior exposure to an anti-igf-1r class compound
boolean
C0332157 (UMLS CUI [1,1])
C4044495 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,3])
C1706082 (UMLS CUI [1,4])
Study Subject Participation Status | Criteria Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])
C0243161 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])